{
    "Trade/Device Name(s)": [
        "Access Hybritech p2PSA QC"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K112603",
    "Predicate Device Reference 510(k) Number(s)": [
        "k993210"
    ],
    "Regulatory Class": "Class I (reserved)",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "August 11, 2011",
    "Summary Letter Received Date": "September 07, 2011",
    "Submission Date": "May 1, 2009",
    "Regulation Number(s)": [
        "21 CFR\u00a7862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "[-2]proPSA isoform of Prostate Specific Antigen (PSA)"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Access Immunoassay Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoenzymatic (Sandwich) assay",
        "Chemiluminescent"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Access Hybritech p2PSA QC tri-level controls for monitoring Access Immunoassay Systems performance in [-2]proPSA quantification.",
    "Indications for Use Summary": "Tri-level controls intended for monitoring system performance of immunoenzymatic procedures for the quantitative measurement of [-2]proPSA isoform of Prostate Specific Antigen (PSA) using the Access Immunoassay Systems.",
    "fda_folder": "Clinical Chemistry"
}